News

FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for ...
TipRanks on MSN5d

FibroGen Gains Approval for Subsidiary Sale to AstraZeneca

FibroGen ( ($FGEN) ) just unveiled an announcement. On August 18, 2025, FibroGen announced that it received regulatory approval from the China ...

FibroGen, Inc.: FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation

Sale of FibroGen China remains on track to close in 3Q 2025 SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the China State Administration for Marke ...
Stocktwits on MSN5d

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca

FibroGen, Inc. (FGEN) on Monday said that a Chinese regulator has approved the sale of its unit FibroGen International (Hong ...
The Globe and Mail4d

Barclays Keeps Their Buy Rating on AstraZeneca (AZN)

Barclays analyst Shirley Chen maintained a Buy rating on AstraZeneca today and set a price target of £140.00. The company’s shares closed yesterday at p11,738.00. Take advantage of TipRanks Premium at ...